← back to search

Michael Li

University of California San Francisco Medical Center · US
Area of research
Hepatology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, and Inflammatory Bowel Disease.
h-index
16
citations
988
works
71
NIH funding
primary concept
Medicine
email

Recent publications

Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study
Journal of Hepatology 2024cited by 69position: middledoi
Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation
Journal of Hepatology 2024cited by 57position: firstdoi
A Comparison of a Large Language Model vs Manual Chart Review for the Extraction of Data Elements From the Electronic Health Record
Gastroenterology 2023cited by 69position: middledoi
Effect of corticosteroid dosing on outcomes in high‐grade immune checkpoint inhibitor hepatitis
Hepatology 2021cited by 62position: firstdoi
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study
Clinical Gastroenterology and Hepatology 2020cited by 251position: middledoi

Grants

Mathematical Approaches to Epidemiological Studies of the Emergence, Re-Emergence and Persistence of Infectious Diseases
NSF0078250$105,0002000–2004PIRePORTER
Mathematical Analysis of Epidemiological Models of SEIRS Type with Varying Population Size
NSF9626128$54,9991996–2000PIRePORTER

Frequent collaborators

Neil Mehta · Institute for Biotechnology and Bioengineering2 papers (2024–2024)Francis Y. Yao · University of California, San Francisco1 papers (2024–2024)Danny Wong · Brigham and Women's Hospital1 papers (2021–2021)Sander Florman · Mount Sinai Hospital1 papers (2024–2024)Myron Schwartz · Mount Sinai Health System1 papers (2024–2024)Maarouf Hoteit · University of California, Los Angeles1 papers (2024–2024)Alexander S. Vogel · Ontario Institute for Cancer Research1 papers (2021–2021)Shilpa Grover · Harvard University1 papers (2021–2021)Jin Ge · University of California, San Francisco1 papers (2023–2023)Kelly Torosian · University of San Diego1 papers (2024–2024)Veeral Ajmera · Liver Institute Northwest1 papers (2024–2024)Parissa Tabrizian · University Health Network1 papers (2024–2024)Gabriel T. Schnickel · University of San Diego1 papers (2024–2024)Stephen D. Zucker · Brigham and Women's Hospital1 papers (2021–2021)Matthew L. Holzner · Mount Sinai Hospital1 papers (2024–2024)Amy K. Kim · Yale Cancer Center1 papers (2024–2024)Jordan Sack · Harvard University1 papers (2021–2021)Sherrie Bhoori · Fondazione IRCCS Istituto Nazionale dei Tumori1 papers (2024–2024)Vincenzo Mazzaferro · Fondazione IRCCS Istituto Nazionale dei Tumori1 papers (2024–2024)Molly Delk · Tulane University1 papers (2023–2023)